![](/static/index/imgs/tc2-1.png)
发表一篇学和医学成像类SCI论文
需要多少钱?
Abstract:
BACKGROUND:This study aimed to compare the treatment response, complications and prognosis in mid-low locally advanced rectal cancer (LARC) patients who underwent stepwise neoadjuvant chemoradiotherapy (SCRT) or traditional neoadjuvant chemoradiotherapy (CRT). METHODS:The medical records of patients with mid-low rectal cancer who underwent SCRT or CRT were retrospectively analyzed. Differences in the treatment response, pathologic complete response (pCR), R0 resection, local recurrence, anastomotic leakage, presacral infection, anal preservation, defunctioning stoma, treatment-emergent adverse events (TEAEs), overall survival (OS) and disease-free survival (DFS) between patients who underwent SCRT and CRT were compared. RESULTS:A total of 430 medical records were investigated, including 194 patients in the SCRT group and 236 patients in the CRT group. There was no significant difference in the rates of treatment response, pCR, R0 resection, local recurrence, anastomotic leakage, presacral infection, anal preservation or TEAEs between the two groups. However, the rate of defunctioning stoma in the SCRT group was significantly lower than that in the CRT group (20.1% vs. 44.1%, respectively, P < 0.01). Moreover, the median OS time of the SCRT and CRT groups was 44.0 and 50.5 months, respectively (P = 0.17). The median DFS time of the SCRT and CRT groups was 41.0 and 46.8 months, respectively (P = 0.32). CONCLUSION:Compared with the CRT group, the SCRT group had a similar treatment response, local control and long-term prognosis, and more importantly, a portion of the patients in the SCRT group were exempted from excessive radiation.
展开更多
最新影响因子:4.037 | 期刊ISSN:0748-7983 | CiteScore: |
出版周期:Monthly | 是否OA:YES | 出版年份:1985 |
期刊官方网址:http://www.ejso.com/
自引率:5.50% | 研究方向:医学-外科 |
出版地区:ENGLAND |
SCI期刊coverage:Science Citation Index Expanded(科学引文索引扩展)
专业编辑在线一对一答疑及时解决您的问题
Surgical Oncology has finally come of age and EJSO continues to play a major role in dissemination of information and knowledge relating to this surgical specialty. Published eight times a year, it presents original articles and state-of-the-art reviews of immediate interest to surgical oncologists. In addition, papers are published on chemotherapy, radiotherapy, epidemiology and pathology of cancer. The articles published also reflect the importance of communication between the laboratory and the clinician. Features Include: Clinical Trials Section Clinical Debate Section Early 'fast-track' publication Regular Reviews Education Section Research Areas Include: Epidemiology and preventive aspects of oncology Diagnosis, including imaging All aspects of therapy, including radiotherapy and chemotherapy Application of new equipment to surgical and clinical oncology Methods of assessing results of treatment Case reports that advance clinical and pathological knowledge Computing in relation to oncology EJSO is abstracted/indexed by: Index Medicus; EMBASE; ASCA; Science Citation Index.
外科肿瘤学终于成熟了,EJSO继续在传播与该外科相关的信息和知识方面发挥着重要作用。每年出版八次,向外科肿瘤学家提供最新的文章和最新的评论。此外,论文还发表在化疗、放疗、流行病学和癌症病理学方面。发表的文章也反映了实验室和临床医生之间交流的重要性。特点包括:临床试验部分临床辩论部分早期“快速通道”出版物定期回顾教育部分研究领域包括:流行病学和肿瘤诊断预防方面,包括影像学治疗的各个方面,包括放射治疗和化疗新设备在外科和临床中的应用。肿瘤学评估肿瘤治疗病例报告结果的方法,推进了与肿瘤学EJSO相关的临床和病理学知识计算,其摘要/索引方法为:索引Medicus;EMBASE;ASCA;科学引文索引。
大类(学科) | 小类(学科) | 学科排名 |
医学 |
ONCOLOGY(肿瘤学) 3区 SURGERY(外科学) 2区 |
87/223 24/200 |
年度总发文量 | 年度论文发表量 | 年度综述发表量 |
278 | 220 | 58 |
引文计数(2018)
文献(2015-2017)
次引用
篇文献
序号 | 类别 | 排名 | 百分位 |
推荐刊物均可到国家新闻出
版总署网站查询正刊
可签署保密协议 ,不透露任
何用户信息可跟踪进程,全程
协议
1对1服务,7x24小时在线
15年经验沉淀,实体公司
运营
liting7111
研究方向:基础 临床 肿瘤
审稿时间: 2个月内 接受率: 比较困难(25%命中)
liting7111
研究方向:肿瘤
审稿时间: 24个月内 接受率: 非常困难(几乎不命中)
liting7111
接受率: 比较困难(25%命中)
liting7111
研究方向:外科 肿瘤
接受率: 一般容易(75%命中)
liting7111
审稿时间: 3个月内 接受率: 中等(50%命中)
影响因子:13.029
ISSN:1522-8517
研究方向:医学-临床神经学
影响因子:4.506
ISSN:0167-594X
研究方向:医学-临床神经学
影响因子:7.723
ISSN:2162-402X
研究方向:ONCOLOGYIMMUNOLOGY-IMMUNOLOGY
影响因子:4.912
ISSN:1524-9557
研究方向:医学-免疫学
影响因子:12.02
ISSN:2326-6066
研究方向:ONCOLOGY-IMMUNOLOGY
影响因子:3.698
ISSN:1750-9378
研究方向:ONCOLOGY-IMMUNOLOGY
影响因子:6.63
ISSN:0340-7004
研究方向:医学-免疫学
影响因子:3.077
ISSN:1534-7354
研究方向:医学-全科医学与补充医学
影响因子:0
ISSN:1868-8497
研究方向:ONCOLOGY-ENDOCRINOLOGY & METABOLISM
专注医学期刊服务15年
您好:请问您咨询什么等级的期刊?专注医学类期刊发表15年口碑企业,为您提供以下服务:
1.医学核心期刊发表-全流程服务
2.医学SCI期刊-全流程服务
3.论文投稿服务-快速报价
4.期刊推荐直至录用,不成功不收费
客服正在输入...
EJSO 投稿经验
(由下方点评分析获得,5人参与,25510人阅读)